More Research

Hutchison China MediTech

ESMO 2020: SANET-p delivers further positive suru data
Update | 22 Sep 2020

Hutchison China MediTech

Innovative pipeline closer to realising its potential
Update | 10 Aug 2020

Hutchison China MediTech

General Atlantic invests $100m at 10% premium
Lighthouse | 25 Jun 2020

Hutchison China MediTech

ASCO 2020: savo and suru data drives regulatory progress
Update | 04 Jun 2020

Hutchison China MediTech

AACR 2020: first surufatinib/PD-1 combo data
Update | 30 Apr 2020

Hutchison China MediTech

Weathering the COVID-19 storm
Update | 20 Apr 2020

Hutchison China MediTech

Laying the foundations for a new era
Outlook | 20 Apr 2020

Hutchison China MediTech

Progress suggests that 2020 will be a decisive year
Lighthouse | 04 Mar 2020

Hutchison China MediTech

A wealth of opportunity for surufatinib
Update | 18 Feb 2020

Hutchison China MediTech

2020 set to be the “breakthrough” year
Update | 27 Jan 2020

1 2 3 4
Return to HUTCHMED
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).